Serum Interleukin-15 Concentration in Patients With Essential Hypertension | Zendy

Masaharu Kaibe | Zendy; Mitsuru Ohishi | Zendy; Nobuyuki Ito | Zendy; Yuan Ma | Zendy; Toshiyuki Takagi | Zendy; Minako TERAI | Zendy; Yuji Tatara | Zendy; N KOMAI | Zendy; Hiromi Rakugi | Zendy; Takehide Ogihara | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Interleukin-15 Concentration in Patients With Essential Hypertension

Author(s) -

Masaharu Kaibe,

Mitsuru Ohishi,

Nobuyuki Ito,

Yuan Ma,

Toshiyuki Takagi,

Minako TERAI,

Yuji Tatara,

N KOMAI,

Hiromi Rakugi,

Takehide Ogihara

Publication year - 2005

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1016/j.amjhyper.2005.02.014

Subject(s) - medicine , coronary artery disease , myocardial infarction , disease , interleukin , artery , inflammation , vascular disease , interleukin 6 , gastroenterology , pathology , immunology , cardiology , cytokine

Interleukin (IL)-15 is one of the cytokines produced by neutrophils and monocytes/macrophages, and its expression is found immunohistochemically in inflammatory cells adjacent to vulnerable atherosclerotic plaques. However, the influence of systemic IL-15 on cardiovascular disease is still unclear. Therefore, we designed clinical investigations to clarify the relationship between cardiovascular complications and serum IL-15 levels.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research